ABSTRACT (250 words) 1 2 Exercise increases mean body temperature ( body ) and cytokine concentrations in plasma. 3
INTRODUCTION 1 2
Humans live with a core temperature within ~5°C of heat-induced death. Body 3 temp erature is thus tightly and powerfully regulated. This is achieved using a 4
proportional control system in which thermoeffectors such as sweating and behavior are 5 activated in response to thermal perturbations of cutaneous and deep tissues. Exercise is 6 the most prevalent, intense thermal perturbation facing humans in contemporary 7 societies; hard exercise can generate sufficient heat to elevate body temperature by 1°C in 8 four minutes. Fever also elevates body temperature, commonly associated with a 9 systemic immune response to trauma, infection or inflammation, possibly via cytokines 10 acting on thermoregulatory structures such as the pre-optic anterior hypothalamus (29, 11 30) . However, exercise also causes cytokinemia and has other effects that might result in 12 pyrogenically-mediated elevation of body temperature. We therefore investigated 13 whether pyrogenic effects of exercise might contribute to exercise-induced hyperthermia 14 in humans. 15 
16
The notion of a fever response to exercise in humans has several lines of support. First, 17 there is a post-exercise elevation in body temperature which is defended, and this is not 18 fully attributable to post-exercise unloading of baroreceptors (28) . Second, there are 19 similarities in the cytokine response between exercise and fever, albeit with a smaller 20 magnitude in exercise (39, 40) . Third, endotoxemia can occur during running and 21 triathlon events (4, 5, 25) . This may be associated with an exercise-induced splanchnic 22 vasoconstriction (42) and tissue heating (36) allowing gut bacteria derived 23 lipopolysaccharide (LPS) endotoxins -a commonly used fever inducing agent -to leak 24 into circulation and trigger an inflammatory response. Finally, perhaps the strongest 25 support comes from early research by Canon and Kluger (7, 8) . They showed that plasma 26 drawn from humans after exercise produced a fever in rats, whereas pre-exercise plasma 27 did not, indicating an exercise-induced accumulation of endogenous pyrogens in 28 circulation (7, 8) . They subsequently examined exercise effects on body temperature and 29
Participants 13
Ten recreationally-active males provided their written, voluntary consent of participation. 14 Their mean age was 23 yr (SD 5), mass was 78. 22 instructed to drink before coming into the lab, but were also required to consume 500 mL 10 of a carbohydrate and electrolyte beverage (8% carbohydrate, 20 mmol·L -1 Na + ) prior to 11 instrumentation. Participants were then weighed (to accuracy of 20 g; Digi D1-10, 12
Teraoka, Seiko Ltd, Tokyo, Japan) before they inserted a rectal thermistor 10 cm beyond 13 the anus, to provide an index of core temperature (T core ). Participants then rested while 14 they were instrumented for measurement of cardiac frequency, skin temperature, sweat 15 rate and forearm perfusion. Resting data, including a resting venous sample (~5 ml, 16 without stasis, 30-min before exercise), were collected. Participants then entered a 17 climatic chamber set at temperate conditions (28ºC, 50% relative humidity and 1.5 m·s electromagnetically-braked cycle ergometer (Rodby Elektronik AB, Södertälje, Sweden). 22
The two exercise modes were separated by a 5-min transition period to set the participant 23 up on the cycle and draw a mid-exercise blood sample (5 ml). Cycling intensity was 24 established for each participant during familiarization to equate with their perceived 25 exertion during the previous running and to facilitate completion of the 45 min. The 26 purpose of using this dual-mode exercise protocol was to elicit substantial strain using 27 running (i.e. orthostatically and mechanically stressful), then maintain it with a mode of 28 exercise that facilitated (a) measurement of forearm perfusion and blood pressure, (b) 29 continued exercise tolerance and (c) additional time for fever effects to become evident. 1
Participants were partially rehydrated with 200 ml after 30 min running and 500 ml after 2 15 min cycling, with the carbohydrate and electrolyte beverage described above. This 3 was done to minimize influences of hyperosmolality and hypovolemia on 4 thermoregulatory control and exercising body temperature, to aid participant tolerance to 5 the exercise regime, and to simulate common practice during prolonged exercise in warm 6 conditions. The trial was stopped if participants requested termination or T core exceeded 7 39.5ºC. Following the 90 min of exercise, participants rested in an upright seated position 8 for 60 min while recovery data were collected. A further blood sample (~5 ml) was taken 9 30-min into this recovery period. 10 Semiconductors LM35CAH, Hong Kong) using a custom-built system. Digital outputs 4 from this system were obtained (PowerLab hardware 8e, ADI Instruments, Chain Hills, 5 NSW, Australia) and recorded on a PC computer via data acquisition software (Chart 6 4.20, ADI instruments, Chain Hills, NSW, Australia). Sweat rates were calculated at 15-s 7 intervals from standard equations, then represented as the mean from both capsules. 8
11

Data Acquisition 12
Humidity sensor calibration was via saturated salt solutions. The 50 and 90% response 9 times to an upward, full scale (0 to 100%) humidity step were 22 and 174 s, respectively. 
Data Analysis 9
Calculations: Mean body temperature ( body ) was calculated from T core and skin using a 10 ratio of 4:1 (12). Thus, body was used in the determination of sudomotor and vasomotor 11 control because it more closely reflects their control than does T core alone. The sweating 12 onset and offset thresholds were calculated by plotting mean sweat rate against body for 13 each participant and visually identifying the body at which sweating increased and 14 continued to rise from baseline (onset), and the body at which the sweating trace 15 returned to baseline and showed no subsequent rises (offset). This was completed by two 16 investigators, both of whom are familiar with these determinations. Forearm vascular 17 conductance (FVC) was calculated as Q & forearm /MAP. 18 
19
Statistics: We are unaware of previous research examining this issue in humans, but we 20 used a sample size of ten because (a) a within-subjects design was used, (b) previous 21 research showed statistically supported effects of NSAID on T core responses to a passive 22 heat stress in four unfit sheep (47) , and to an exercising stress in seven iguana (7), and (c) 23 we had previously obtained statistically supported effects of COX-2 specific inhibitors on 24 renal function using twelve participants (1). Fully-repeated two-way ANOVA were used 25 to examine the effects of NSAID administration on the relevant dependent variables. measurement during the initial heat stress period. Therefore, the change in FVC from rest 26 to cycling exercise was used and normalized to the change in body . The FVC response 27 was significantly higher in NSAID than in PLAC (0.13 versus 0.10 ml·100 ml tissue To the best of our knowledge, this study provides the first direct evidence that a 3 supplemental fever-like elevation in body temperature can occur during non-exhaustive 4 exercise in humans. Administration of a COX-2 selective inhibitor lowered core and 5 mean body temperatures during exercise and ensuing recovery, relative to the 6 temperatures obtained following administration of a placebo. This was independent of 7 endogenous heat stress or thermal environment. More importantly in relation to the 8 notion of an exercise-induced fever, administration of a COX-2 specific inhibitor was 9 associated with an unchanged body at which sweating was initiated but a relative 10 lowering of the body at which sweating ceased in recovery from exercise, and a greater 11 increase in FVC relative to body in the latter portion of exercise. The post-exercise 12 elevation in the body threshold for sweating cessation observed in both conditions was 13 expected due to effects of non-thermal factors, particularly the baroreceptor unloading 14 due to residual vasodilation of skeletal muscle (28) . These data therefore support our 15 hypothesis and confirm, in humans, the work using animal models (7, 8, 47) , that a 16 pyrogenic effect can develop during exercise. 17
18
The inhibition of COX-2 enzymes in this study served our aim of identifying a fever-like 19 effect during exercise, but the intervention has limitations. Fever is complex, likely 20 inducible via numerous pyrogens and pathways, some of which remain unknown (3, 31, 21 52). Of those proposed, PGE 2 has been suggested as a common mediator in raising the 22 thermoregulatory set point (61) . However, even though COX-2 enzymes have been 23
repeatedly associated with the production of PGE 2 largely responsible for fever and 24 inflammation (23, 33, 49, 55) , there is evidence for COX-1 having a regulatory role and 25 for non-COX pathways (2, 58) . Thus, we are unaware whether the difference of 0.3°C 26 (~20% of end exercise elevation in T core ) seen between the two groups was the entire 27 pyrogenic response. These issues could be addressed using non-selective NSAIDs (COX-28 (paracetamol) which have anti-pyretic actions independent of COX inhibition. Equally, 1 whether any fever-like effect would develop in non-exhaustive exercise of similar 2 duration and intensity in endurance trained individuals is unknown. 3 4 This has been examined in sheep exposed to passive heat stress (47) . The approximately 5 0.3°C attenuation in a 1.7°C hyperthermia in the present study ( Figure 1A ) was of similar 6 magnitude to that observed in unfit sheep exposed to passive heat stress (~0.3°C in 1.3°C; 7 (47)). In that study, no decrease in T core was seen in fit sheep, who possessed a higher 8 splanchnic perfusion during heat stress that matched the baseline perfusion of the unfit 9
sheep. Whether aerobically conditioned humans would similarly show no effect is 10 unclear, but several factors indicate that such effects might occur. In most exercise 11 settings they undergo higher absolute volumes of stress in accordance with their higher 12 fitness. They can also suffer heat stroke. They have an anti-LPS IGg elevation that is 13
proportional to their training volume and is diminished during exhaustive, competitive 14 exercise (5, 25). Despite their larger splanchnic vessels (13) to elevate the thermoregulatory set point, seems more likely to be responsible for the 26 maintenance of a fever response (2) . The extent to which cytokines can cross the blood-27 brain barrier and act directly or indirectly on thermoregulatory neurones is unclear, but 28 endurance exercise seems to impair the integrity of this barrier, at least in hot conditions 29 (59) . It should also be considered that NSAIDs readily cross this barrier, thus local COX 1 inhibition may attenuate PG production in response to stimuli of local, humoral or 2 afferent neural origin. The time course of a NSAID-associated attenuation of T core in the 3 present study ( Figure 1A ) unfortunately coincided with changing of exercise mode and 4 the slight reduction in metabolic heat production. Nonetheless, the time course seemed to 5 be more indicative of a humorally mediated fever (44, 45), which would also be 6 consistent with the mechanism of intervention, i.e., COX-2 inhibition of PG production. 7 8 Endurance exercise may be capable of inducing a sub-clinical pyrogenic response, which, 9 acting in concert with other fatigue processes, is usually self limiting before the 10 development of exertional heat stroke (19) (20) (21) . The source and identity of pyrogenic 11 factors could potentially include pro-inflammatory cytokines (e.g., IL-1, TNF-, IL-6), 12 mainly from muscle, liver, leukocytes, adipose tissue or the central nervous system itself, 13 LPS leaking across the gut wall, and/or cellular constituents from within muscle or other 14 stressed tissue. These factors might act humorally, via cytokines, or neurally. 15
16
A probable source of a pyrogenic response is increased LPS from the GI tract in response 17 to prolonged splanchnic vasoconstriction and elevated tissue temperature (4, 8, 14, 15, 18 18-21, 47) . LPS leakage is normally low enough for hepatic detoxification and anti- LPS 19 antibodies to keep pace. However, epithelial permeability and LPS leakage increase with 20 a variety of factors, including local temperature (36, 50) and ischemia (14, 15) . Increased 21 LPS leakage can deplete antibodies and saturate hepatic clearance, increasing the LPS 22 load and activating mediators of the non-specific immune system (cytokines, interferon), 23 vascular reactivity (PGEs) and coagulation (Factor XII), initially causing inflammatory 24 and fever-producing effects. In advanced stages this appears to underlie exertional heat 25 stroke (20) . However, data obtained from animal models indicates that even lower (i.e. 26 sub-lethal) endotoxic loads may reduce heat tolerance (19) , particularly if endurance 27 fitness is limited (47) . 28 Interleukin 6 (IL-6) release is stimulated by TNF-, but also inhibits production of TNF-1 , and in this respect has been proposed to have an important anti-inflammatory role as 2 well as a pro-inflammatory role. It is now known to be released mostly from active 3 muscle in endurance exercise, and seems to lower self-selected exercise intensity (43). 4
Because of the pluripotential role of IL-6, we used TNF-as a marker of the 5 inflammatory cytokine response, but saw little change across exercise, and no differential 6 response with Rofecoxib compared to placebo. Thus, our cytokine measurements provide 7 no explanation for our findings, but we do not consider IL-6 release from active muscle 8 as the most likely source of pyrogens. 9
10
Finally, responses to muscle tissue damage may also drive an exercise-induced 11 inflammatory response. However, this effect has only been evidenced from higher 12 exercising T core during exercise performed many hours after the damaging stimulus (6, 13 34) , and may depend on prior migration of activating agents such as neutrophils, 14 macrophages, and PAF (41, 51) . The exercise undertaken in this study was not to 15 exhaustion and none of the subjects reported difficulty or injury as a consequence of the 16 exercise schedules. Even so, this study design does not allow us to exclude a potential 17 acute effect of muscle damage on the pyrogenic response observed. 18 
19
Recent studies using passively-induced hyperthermia have demonstrated that heat-related 20 impairment of force development is attributable to both central and peripheral effects (35, 21 54) . Thus, high body temperature itself can impair exercise tolerance independently of its 22 effects in elevating cardiovascular, metabolic and neuroendocrine strain. Minimizing the 23 fever component of any such hyperthermia would therefore seem beneficial. 24
25
The use of NSAIDs during exercise, presumably for musculoskeletal injuries, appears to 26 be widespread. Seventy two percent of runners in an ultra-endurance race reported 27
consuming NSAIDs, and, interestingly, the inflammatory cytokine profile of those 28 runners was higher than that of non-users following the 100-mile race (37). Also 29 widespread is the belief that COX-2 selective NSAIDs avoid some dangers of non-1 selective NSAIDs, such as hyponatremia. However, COX-2 selective inhibition has been 2 found to reduce free water clearance during and following endurance exercise to an 3 extent similar to non-selective COX inhibition (1), along with the potential for a 4 significant reduction in renal blood flow and glomerular filtration rate. Thus, even if 5 attenuation of hyperthermia was known to be useful in a given athletic or occupational 6 endeavor, and COX-2 selective inhibition was shown effective in that setting, the effect 7 of ~0.3°C magnitude reduction in T core would be realistically achieved by a strategy 8 focusing on adequate hydration, aerobic training, heat accl imatization , weight control, 9 cooling, and possibly dietary modification, rather than the use of COX-2 inhibitors. In at 10 risk individuals, COX-2 inhibition as well as non-selective COX inhibition may carry an 11 increased risk of cardiovascular events (26) . The potential risk of COX-2 inhibitor 12 associated cardiovascular event in athletes is unknown, but in light of the above 13 discussion, we would recommend caution in the use of these agents in moderate to severe 14 exercise. 15
16
Another limitation of using the COX-2 selective inhibitor to examine whether exercise 17 can induce a fever response is that the drug may have a confounding influence on 18 exercise thermoregulation. Whilst we believe that our hypothesis is supported primarily 19 by virtue of the lower sweat offset threshold for NSAID compared with PLAC in the 20 absence of a shift in MAP, the reduction of cardiovascular strain that was evident with 21 NSAID usage in this study (cardiac frequency lower by ~6 ·min -1 ; Figure 3 ) is harder to 22 explain. A direct Q 10 effect chronotropically should only drop the frequency by ~2 min -1 , 23 and whilst circulating catecholamine levels might further contribute, that should have 24 been evident in measures such as the respiratory exchange ratio and MAP (both of which 25 were equivalent). However, there may also be a direct effect of prostanoids on cardiac 26 frequency (53), as evidenced from mice lacking TP and FP receptors (for the prostanoids 27 thromboxane A 2 and prostaglandin F 2 , respectively). Relative to wild-type mice, the 28 gene-deleted mice showed inhibition of inflammatory tachycardia, apparently via direct 29 action of these prostanoids on cardiac pacemaker cells rather than effects on sympathetic 1 activity. Thus, use of a COX-2 inhibitor in our study could possibly have attenuated 2 PGF 2 production and exerted a direct negative chronotropic effect despite the low 3 dosage we used. 4
5
Regarding other possible cardiovascular effects, inhibition of COX-2 mediated PGE 2 6 production has been found, with higher drug dosages, to attenuate exercise hyperemia in 7 endurance-exercised connective tissue (32) , and prostacyclin (PGI 2 ) has been shown to 8 impact on maintenance of resting forearm blood flow (11) . In contrast, non-selective 9 COX-inhibition with Aspirin had no effect on resting forearm blood flow but did reduce 10 vasodilation following isometric contraction of the forearm muscles at 60% MVC (60). 11
Whether such effects could have impacted on cutaneous perfusion in this study is 12
unknown, but we also note that there seems to be considerable redundancy among 13 vasodilatory pathways (e.g., involving prostaglandins and prostacyclins, acetylcholine, 14 nitrous oxide and potassium; (9, 11, 32, 60) ), such that non-thermoregulatory effects on 15 exercise hyperemia might have been negligible. Finally, since we used a 5-d ingestion 16 protocol (to attain steady state COX-2 inhibition before first assessing resting 17 thermoregulation), we cannot preclude the possibility of a short-term adaptive response to 18 COX-2 inhibition. 19 
20
In conclusion, sub-maximal endurance exercise can induce a fever-like response in 21 humans which causes a supplementary increase in mean body temperature, possibly via 22 the effects of COX-2 mediated PGE 2 production on the thermoregulatory set point. 23
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